Literature DB >> 8943073

Intrastriatally injected c-fos antisense oligonucleotide interferes with striatonigral but not striatopallidal gamma-aminobutyric acid transmission in the conscious rat.

W Sommer1, R Rimondini, W O'Connor, A C Hansson, U Ungerstedt, K Fuxe.   

Abstract

Antisense c-fos oligonucleotides injected into the neostriatum of conscious rats selectively inhibited c-fos expression associated with compensatory increases in striatal c-fos mRNA levels and also with increased expression of junB and NGFI-A mRNA, probably as a result of regulatory phenomena. Dual probe in vivo microdialysis was used to investigate gamma-aminobutyric acid (GABA) release in the substantia nigra and the globus pallidus, which represent the terminal sites of the dopamine D1 receptor regulated striatonigral and the dopamine D2 receptor regulated striatopallidal GABA pathways, respectively. Intrastriatal infusion of the c-fos antisense oligonucleotide profoundly decreased dialysate GABA levels in the ipsilateral substantia nigra within 60 min but did not influence the dialysate GABA levels in the globus pallidus compared with the sham and control oligonucleotide treated groups. The site of action of the antisense oligonucleotides was mainly restricted to striatal neurons as shown by the distribution of locally injected fluoresceine isothiocyanate and radiolabeled oligonucleotides. The findings demonstrate a facilitatory role for c-fos mediated gene regulation in striatonigral GABA transmission and strengthen the evidence that the regulation of neurotransmission is different in the striatonigral and striatopallidal GABA pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943073      PMCID: PMC19506          DOI: 10.1073/pnas.93.24.14134

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.

Authors:  J I Morgan; T Curran
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

2.  Structure of the NGFI-A gene and detection of upstream sequences responsible for its transcriptional induction by nerve growth factor.

Authors:  P S Changelian; P Feng; T C King; J Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain.

Authors:  S Ferré; W T O'Connor; K Fuxe; U Ungerstedt
Journal:  J Neurosci       Date:  1993-12       Impact factor: 6.167

4.  Complex genetic organization of junB: multiple blocks of flanking evolutionarily conserved sequence at the murine and human junB loci.

Authors:  D G Phinney; S W Tseng; K Ryder
Journal:  Genomics       Date:  1995-07-20       Impact factor: 5.736

5.  Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos.

Authors:  G S Robertson; S R Vincent; H C Fibiger
Journal:  Brain Res       Date:  1990-07-23       Impact factor: 3.252

6.  D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.

Authors:  M L Paul; A M Graybiel; J C David; H A Robertson
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

7.  Striatal c-fos Induction by Cocaine or Apomorphine Occurs Preferentially in Output Neurons Projecting to the Substantia Nigra in the Rat.

Authors:  M. Angela Cenci; Kenneth Campbell; Klas Wictorin; Anders Björklund
Journal:  Eur J Neurosci       Date:  1992       Impact factor: 3.386

8.  Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA.

Authors:  P K Liu; A Salminen; Y Y He; M H Jiang; J J Xue; J S Liu; C Y Hsu
Journal:  Ann Neurol       Date:  1994-10       Impact factor: 10.422

9.  fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system.

Authors:  R J Smeyne; K Schilling; L Robertson; D Luk; J Oberdick; T Curran; J I Morgan
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

10.  Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene.

Authors:  C Le Moine; E Normand; B Bloch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

View more
  6 in total

1.  Choice for Drug or Natural Reward Engages Largely Overlapping Neuronal Ensembles in the Infralimbic Prefrontal Cortex.

Authors:  Simone Pfarr; Laura Schaaf; Janine K Reinert; Elisabeth Paul; Frank Herrmannsdörfer; Martin Roßmanith; Thomas Kuner; Anita C Hansson; Rainer Spanagel; Christoph Körber; Wolfgang H Sommer
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

2.  From synapse to gene product: prolonged expression of c-fos induced by a single microinjection of carbachol in the pontomesencephalic tegmentum.

Authors:  James J Quattrochi; Mihaela Bazalakova; J Allan Hobson
Journal:  Brain Res Mol Brain Res       Date:  2005-03-23

3.  Dopamine systems adaptation during acquisition and consolidation of a skill.

Authors:  Wolfgang H Sommer; Rui M Costa; Anita C Hansson
Journal:  Front Integr Neurosci       Date:  2014-11-05

4.  Ethanol-induced alterations of amino acids measured by in vivo microdialysis in rats: a meta-analysis.

Authors:  Sarah Fliegel; Ines Brand; Rainer Spanagel; Hamid R Noori
Journal:  In Silico Pharmacol       Date:  2013-05-17

Review 5.  Developing neuroscience-based treatments for alcohol addiction: A matter of choice?

Authors:  Markus Heilig; Eric Augier; Simone Pfarr; Wolfgang H Sommer
Journal:  Transl Psychiatry       Date:  2019-10-08       Impact factor: 6.222

6.  Losing Control: Excessive Alcohol Seeking after Selective Inactivation of Cue-Responsive Neurons in the Infralimbic Cortex.

Authors:  Simone Pfarr; Marcus W Meinhardt; Manuela L Klee; Anita C Hansson; Valentina Vengeliene; Kai Schönig; Dusan Bartsch; Bruce T Hope; Rainer Spanagel; Wolfgang H Sommer
Journal:  J Neurosci       Date:  2015-07-29       Impact factor: 6.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.